LOWY: Paylines are dropping because NCI is drawing more applicants who would’ve previously gone elsewhere December 06, 2019Vol.45 No.45By Matthew Bin Han Ong
Drugs & Targets FDA takes second action under international collaboration, approving treatment option for CLL or SLL November 22, 2019Vol.45 No.44
Drugs & Targets FDA grants Q BioMed approval to manufacture non-opioid cancer palliation drug November 22, 2019Vol.45 No.44
Drugs & Targets FDA approves crizanlizumab-tmca for sickle cell disease November 22, 2019Vol.45 No.44
Drugs & Targets European Commission approves two regimens of Keytruda for front-line metastatic, unresectable HNSCC November 22, 2019Vol.45 No.44
Drugs & Targets European Commission grants marketing authorization for Darzalex + lenalidomide and dexamethasone in frontline MM November 22, 2019Vol.45 No.44
Drugs & Targets Japan grants approval of Myriad Genetics’ BRACAnalysis Diagnostic System for breast cancer patients November 22, 2019Vol.45 No.44
Clinical Roundup Care in a multidisciplinary prostate cancer clinic increases discussion of treatment options, adherence to guidelines November 22, 2019Vol.45 No.44
Clinical Roundup UCSD researchers focus on persistent opioid use, abuse and toxicity among cancer survivors November 22, 2019Vol.45 No.44
